Purpose: This study demonstrates a DCE-MRI estimate of tumor interstitial fluid pressure (TIFP) and hydraulic conductivity in a rat model of glioblastoma, with validation against an invasive wick-in-needle (WIN) technique. An elevated TIFP is considered a mark of aggressiveness, and a decreased TIFP a predictor of response to therapy.
Interstitial fluid pressure (IFP) is elevated in most solid tumors. This elevated pressure is caused by the abnormal structure and function of tumor blood vessels, tumor lymphatics, and interstitium. 1, 2 Experimental and clinical studies have demonstrated that increased tumor IFP (TIFP) reduces therapeutic efficiency. 3, 4 Tumor IFP is an independent prognostic parameter for tumor aggressiveness, tumor response, and treatment outcome. 4, 5 Both in animal 6 and human studies, 7 TIFP is studied by such invasive methods as the wick-in-needle (WIN) technique. However, the WIN measurement is not easily repeated, and is clinically applicable only in locations where the tumor can be reached easily. Thus, developing a noninvasive and repeatable method to estimate TIFP as a biomarker in typically inaccessible brain tumors is a significant step forward in the assessment of tumor response to therapeutic interventions.
The noninvasive evaluation of TIFP using DCE-MRI has been explored in a limited number of studies. Pishko et al 8 used a model of interstitial transport of contrast in porous media to estimate the flow and pressure of interstitial fluid, showing increased central TIFP and higher exudate streaming velocities at the tumor boundaries. However, these estimates lacked validation by invasive measurements. Hassid et al, 9 studying a mouse model of non-smallcell lung cancer, used a slow infusion of the contrast agent gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) into the blood for approximately 2 hours. They showed that parametric images of steady-state tissue Gd-DTPA concentration of the tumors and their surroundings reflected the spatial distribution of the IFP. However, the scaling methods outlined would make an absolute estimate of TIFP unreliable if the experiment were to be repeated in a different set of animals. Furthermore, a study of this type is clearly impractical in human subjects, both because of the length of the study and the amount of contrast agent required.
Other DCE-MRI studies 10, 11 evaluated TIFP using parameters that related to tumor perfusion and permeability. However, the resulting estimates were not well correlated with needle-based TIFP measurements. Using a different approach, in a DCE-MRI experiment, the velocity of interstitial fluid flow along a line drawn normal to the tumor surface was proposed as a measure of central TIFP, 12 but this approach may be unreliable if the velocity along different perpendiculars varies. In this study, 2 approaches using DCE-MRI to model TIFP are presented. The first approach is based on a wellrecognized fluid-mechanical model of flow in porous media, whereas the second uses a multivariate analysis of MRI vascular parameters as predictors of TIFP to generate an empirical model. The fluid-mechanics approach demonstrates that, given good estimates for fluid-mechanical constants, the underlying physical mechanical system can be understood in the framework of classical poroelastic theory; the empirical approach confirms that MRI studies contain sufficient information to predict TIFP noninvasively.
The fluid-mechanical model for estimating TIFP depends on a measurement of the mean flux of a contrast agent (CA) at the tumor periphery. By Darcy's law, 13 this flux is driven by the IFP gradient at the tumor surface, and by such characteristics of the interstitium as porosity and interstitial hydraulic conductivity. Hydraulic conductivity will be estimated by using the Kozeny-Carman (KC) equation, 4 and TIFP via
Darcy's law. Both approaches to estimating TIFP include groups of animals with and without treatment, and use parameters produced by a model selection paradigm 15 and the Patlak and
Logan plots applied to DCE-MRI data. 16, 17 The MRI-TIFP estimates are compared with the WIN-TIFP measurements performed immediately after the DCE-MRI study.
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| U251 animal model of orthotopic brain tumor
These studies were conducted with the approval of the Institutional Animal Care and Use Committee. A U251 model of embedded cerebral tumor was studied in 36 athymic female rats (weight of approximately 200 g; Charles River, Wilmington, MA). Animals were anesthetized with isoflurane (4% for induction, 0.75 to 1.5% for maintenance, balance N 2 O:O 2 5 2:1). The surgical zone was swabbed with Betadine solution, the eyes coated with Lacri-lube, and the head immobilized in a small animal stereotactic device (Kopf Instruments, Tujunga, CA). After draping, a 1-cm incision was made 2 mm to the right of the midline and the skull was exposed. A burr hole was drilled 3.5 mm to the right of bregma, taking care not to penetrate the dura mater. A 10-lL Hamilton syringe with a 26-gauge needle (Model 701, Reno, NV) containing U251 tumor cells freshly harvested from log phase growth (5 3 10 5 in 10 ll of phosphate-buffered saline) was lowered to a depth of 3.0 mm and then raised back to a depth of 2.5 mm to create a pocket. Cells were injected at a rate of 0.5 lL/10 seconds until the entire volume was injected. The syringe was then slowly withdrawn, the burr hole sealed with sterile bone wax, and the skin sutured. Tumors in animals implanted following this technique grew to 3 to 6 mm diameter by approximately 18 6 3 days after implantation.
| Experimental preparation and protocol
Approximately 18 days after implantation, rats underwent a high-resolution T 1 -weighted MRI study to determine tumor size and tumor location. When tumors grew to approximately 6 mm in diameter (range $3 to 8 mm), a DCE-MRI study was conducted in each animal, followed by the WIN-TIFP measurement. A high-resolution T 2 -weighted MRI after TIFP measurement verified that the needle path went through the tumor. Immediately after the T 2 -weighted MRI to determine the needle path, the animal was euthanized and its brain removed for histology.
In addition to studies in controls, in the course of other studies in tumors, [18] [19] [20] a number of treatments were applied that generated variations in TIFP after treatment. Four groups of rats were studied: a control group (n 5 13), a group treated with bevacizumab (Avastin) (n 5 9), a group treated with a combined therapy of Cilengitide and radiation therapy (RT) (n 5 10), and an RT monotherapy group (n 5 4). bevacizumab was administered as a single dose intravenously for 30 minutes at a dose of 10 mg/kg and delivered at selected time points of 2, 4, 8, 12, and 24 hours before the MRI study. In the combined therapy, Cilengitide was given as a single dose (4 mg/kg, intraperitoneal) prior to a 20-Gy single fraction radiation exposure as described previously. 21 In the RT monotherapy group, RT was administered as a 10-Gy single dose of irradiation at selected time points of 24 and 48 hours before the MRI study. 22 
| Magnetic resonance imaging studies
All MRI studies were performed using a 7T magnet in a Varian (Santa Clara, CA) 20-cm bore system with a direct drive spectrometer and console. Gradient maximum strengths and rise times were 250 mT/m and 120 ms, respectively. All MRI image sets were acquired with a 32 3 32 mm 2 FOV. The transmit coil was a RAPID (MR International, Columbus, OH) quadrature birdcage coil; the receive coil was a RAPID 2-channel phased-array surface coil for rat brain imaging. Arterial spin labeling, DCE-MRI, Look-Locker, T 1 -weighted, and T 2 -weighted image sets were acquired and used to derive the tumor parameters that were used in both the fluid-mechanical model, and in multivariate empirical estimates of TIFP. Spin-echo arterial spin-labeled data were acquired to estimate cerebral blood flow in a single central slice, as previously described. 23 The MRI parameters were as follows: Two high-resolution T 1 -weighted spin-echo images were acquired before and after CA, to locate the tumor and its size, with the following parameters: FA 5 45 8 and 180 8, 
| Tumor vascular parameters
The DCE-MRI analysis that was used to derive vascular parameters for estimating TIFP used a model selection paradigm 15 based on Patlak graphical methods. 24, 25 The model selection generated maps of brain regions and labeled them with the number of parameters used to describe the data. This resulted in the following regions: (1) Model 1 region: essentially normal vasculature with no leakage, in which only filling of the vasculature with CA occurs; (2) Model 2 region: measurable leakage from the microvasculature to the interstitial space, but lacking evidence of reflux of CA from the interstitial space to the vasculature; and (3) Model 3 region: highly leaky vessels with measurable reflux of CA from the interstitial space to the microvasculature ( Figure  1A) . A model-selection paradigm has the advantage, especially in the brain, that the border between tumor and surrounding normal tissue can be well defined by the spatially changing permeability of the tissue, with the tumor vasculature typically permeable to a contrast agent, and the normal tissue typically impermeable across the time of the 10-minute DCE-MRI study. Model selection was used to describe the tumor region of interest (ROI), and to define an ROI of the tumor periphery consisting mostly of normal tissue. The analysis that estimated extracellular space in regions selected as Model 3 used an adaptation of the Logan graphical method 26 that has been verified, both against histology and by comparison to similar estimates generated by the extended Tofts model. 17 In all animals, postcontrast T 1 - Ref 27 addresses the estimation of extracellular space in the mostly normal rim. It is assumed that the CA is not reabsorbed in the microvasculature of the mostly normal rim, and that at some time point in the experiment the concentration of CA leaving the normal rim equilibrates with the concentration of CA entering the normal rim. This assumption can be verified (and the time of equilibration identified) by Using the same assumptions, a larger ROI can be drawn in the normal region around the tumor, and the accumulation of CA can be followed over time. Again, using the inner adjacent tumor voxels as a forcing function, a Patlak-like plot can be constructed, the slope of which is the flow of tumor exudate into the ROI. A simple calculation for the area of the perimeter of the tumor yields flux from the tumor. See 
| Wick-in-needle TIFP measurement
The TIFP was measured by inserting into the tumor a 23-gauge fluid-filled needle with a 2-mm-long side port located approximately 3.5 mm from the needle tip. The distal section of approximately 1 to 2 cm of needle was filled with a polyester multifilament thread. The 23-gauge needle was connected directly to 1-mL plastic syringe through a Luer-Lock connection, and the syringe was coupled with approximately 20 cm of polyethylene tubing to a TruWave pressure transducer (model PX600F; Edwards Lifesciences LLC, Irvine, CA), and thence to a strain gauge meter (model PAXLSG, Red Lion Controls, York, PA). The needle and the polyethylene tubing were filled with artificial CSF (150 mM Na, 3 mM K, 1.4 mM Ca, 0.8 mM Mg, 1.0 mM P, and 155 mM Cl), and care was taken to eliminate all air bubbles within the system. Zero reference pressure was determined by placing the needle in a beaker filled with artificial CSF at the level of the needle insertion. The transducer and the strain gauge meter were calibrated to provide a 1 mV reading, corresponding to 1 mmHg. The continuously anesthetized animal was removed from the MRI scanner for a WIN-TIFP measurement. With the rat's head immobilized on the same stereotactic device as used for tumor implantation, the WIN needle fixed vertically on the device and the pressure transducer located at the level of the rat's head, a midline incision was made and the skull exposed. The WIN needle was inserted vertically into the tumor through the existing burr hole made for tumor cell implantation, and advanced into the tumor in steps of 0.5 mm and held stationary in each step until the pressure reading stabilized, after which the TIFP was recorded for approximately 2 minutes with a sampling rate of 1 reading per 5 seconds. In this manner, the TIFP was measured along the tumor diameter, and the pressure-depth profile was established. Using the pressure-depth profile, TIFP values were averaged around the plateau region and the length of the pressure gradient was calculated as the distance of the increase in IFP from atmospheric pressure to plateau values. As noted, following the WIN-TIFP measurement, a second T 2 -weighted MRI was acquired to check that the path of the needle lay in the central slice of the DCE-MRI measurement. The needle path was also confirmed in the postmortem histology slides.
| Estimates of TIFP using the Darcy equation (fluid-mechanical model)
It has been experimentally 28 and mathematically 29, 30 established that IFP in an embedded tumor is uniform and elevated throughout the tumor center, and decreases steeply to normal tissue values at the tumor surface. Because interstitial flow occurs only in the presence of a pressure gradient, advection in the tumor occurs almost exclusively near the tumor surface, from the tumor periphery into the surrounding normal tissue. 1 We assume the tumor to be a porous media with fluid transport in the tumor described by Darcy's law. 13 Darcy's law relates the IFP gradient and the velocity of exudate fluid at each point on the tumor surface through a local constant, the hydraulic conductivity, as follows:
where v is the fluid velocity vector, $p is the pressure gradient vector, and K is the hydraulic conductivity of the tissue.
In this paper, we will assume that conductivity is locally isotropic. A simplifying approximation for Darcy's law was used to estimate the central pressure of an embedded tumor. As shown in Figure 3A , Darcy's law will be approximated across short distances as v5K
l , where p i is the TIFP, p 0 is the IFP in the normal tissue, which is approximately at atmospheric pressure, 4 and l is the length of the pressure gradient. Thus, to estimate TIFP noninvasively, an estimate of the fluid velocity at the tumor surface and the hydraulic conductivity of the tissue are required. Hydraulic conductivity depends primarily on the porosity of the medium and the viscosity of the fluid passing through the pores.
14 It quantifies the ability of a porous medium to transmit fluids through its interconnected pores or channels when the fluid experiences a pressure gradient. Hydraulic conductivity depends on a combination of several microstructural parameters, including porosity, pore or grain size, and tortuosity. 1 It can be viewed as a system property of a biological tissue, and can be described by the well-known KC equation 14 as
where u is the porosity and m is the viscosity of the interstitial fluid; m ranges from 3.0-3. The total specific surface area (S) is defined as the area of the surface that is exposed to the fluid per unit bulk volume. S depends on the geometrical structure of the pores, and has been commonly related to pore or grain diameters. 14 The S of a porous material can be affected by porosity, packing mode, grain size, and shape. 32 In our case, the material defining the grains consists of the cells and the extracellular matrix of the tumor tissue, rendering an estimate of S on the basis of shape infeasible. Estimating the grains' surface area based only on the cells' surface area will underestimate S, and thus bias high the estimated hydraulic conductivity. To add difficulty, we found no estimate of S in the literature. Accordingly, to approximate S values in the U251 tumor control sample, the KC equation was incorporated in Darcy's law, and a regression analysis was applied to the quantities
versus p i , with the intercept set to zero. In this case, S equals the square root of the reciprocal of the slope. Using control sample experimental measures of WIN-TIFP, and MRI estimates of v and u, the value of S was calculated. As a first-order comparison, these estimates of S were checked against the mean of S calculated from the range of previously reported hydraulic conductivity values, 33, 34 to account for the variation in S across tumors using Equation 2 and the tumor porosity reported in each study. After determining the value of S in the ROI of the tumor, and using the previously acquired experimental estimates of porosity, 17 the hydraulic conductivity (MRI-K) was derived using the KC relationship. Using the methods of reference, 16 the mean velocity of exudate fluid (v) across the surface of the tumor was estimated. Using the pressure-depth profile, the length of the pressure gradient was calculated. Thus, by Darcy's equation, the necessary parameters to estimate TIFP noninvasively were on hand. We note that fluid velocity was estimated via an estimate of flux in the mostly normal rim of the tumor. Conductivity was estimated from DCE-MRI measures in the tumor itself. Thus, different regions were used to estimate these 2 parameters, and the concern that a single data set was overfitted is substantially diminished.
| Regression of MRI measures of tumor physiology against WIN-TIFP (empirical model)
We had on hand a number of MRI measures of tumor physiology, many of which might be considered relevant to fluid supply to the tumor, fluid drainage from the tumor, and/or resistance to interstitial flow in and around the tumor. We The WIN-TIFP measures were tested for normality; when the Shapiro-Wilk test demonstrated a nonnormal distribution in WIN-TIFP, the values were log-transformed. A multivariate analysis on the log-transformed data was performed to test for a set of MRI vascular parameters that best predicted (the log of) WIN-TIFP in the tumor. The best predictors to describe TIFP were chosen based on the Akaike information criterion (AIC). The data were analyzed as one set, taking into account the effect of the different treatment groups represented by indicator variables (i.e., each treatment group had its own intercept in the model).
After determining the best predictors of log TIFP, a regression analysis was applied using these predictors, and the regression coefficients of these parameters were obtained. An empirical model for estimating TIFP (MRI-TIFP E ) was established for the whole data set, and separately for each group. The model fits were verified against the WIN-TIFP by a crossvalidation leave-one-out method. Coefficients of determination as estimated by cross-validation (using the R package cv.lm 35 are also reported. A secondary analysis with WIN-TIFP not logtransformed was also conducted but is not reported, as it resulted in essentially the same outcomes as in the main analysis.
| Statistical methods
All statistics are reported as mean 6 SD. The R Statistical Environment 36 was used for all statistical analyses. An initial analysis for correlation between the WIN-TIFP and MRI-TIFP estimates was performed using linear and multiple linear regression, followed by a leave-one-out cross-validation. The coefficient of determination (R 2 ) was calculated by a simple regression followed by a leave-one-out cross validation using a linear model (routine cv.lm in the R statistical package). A Shapiro-Wilk test was used to test normality. A p value 0.05 was considered statistically significant.
| R ES ULT S
| Wick-in-needle TIFP measurements and profiles
The WIN-TIFP measurements were performed on 36 animals. The TIFP was recorded as a function of tumor depth, and the pressure-depth profile was created for each animal. The TIFP rose rapidly in the tumor periphery, reached a maximum value, and remained relatively uniform throughout the tumor; these results closely resembled those of previous investigators.
28,37 Figure 3B shows a representative pressure profile (a representative profile in normal tissue is shown in Supporting Information Figure S1 ). In typical measurements in tumors, a sharp increase in IFP from atmospheric pressure to plateau values was within 1.0 to 2.5 mm of the tumor boundary, with a mean of 1.66 6 0.48 mm. The TIFP values were averaged around the plateau region for each animal, and the sample mean of TIFP for the control group was 6.0 6 3.7 mmHg with range of 1.6 to 14.9 mmHg.
| Dynamic contrast-enhanced MRI estimates of hydraulic conductivity
To estimate hydraulic conductivity of the tumor as described in Equation 2, the total specific surface area of the cells and extracellular matrix, and the tumor porosity, were estimated. An estimate of S that included both cells and extracellular matrix was generated by regressing flux versus central pressure and applying Equation 2. The slope of the regression analysis with the intercept set to zero for the experimental data was 4. ) calculated from previously reported hydraulic conductivities and porosities in other tumors. 33, 34 By using an individual animal's estimate of porosity and the group S value in Equation 2, the hydraulic conductivity was calculated for each animal; the mean estimated hydraulic conductivity (MRI-K) was (2.3 6 3.1) 3 10 25 mm 2 /mmHg-s for the control group, in general agreement with other reports in other tumor models. 33, 34, 38, 39 
| Darcy's estimates of TIFP (fluid-mechanical model)
By using the mean estimated exudate fluid velocity at the tumor surface and the estimated MRI-K for each animal in 
| Multivariate analysis and regression of WIN-TIFP and MRI vascular parameters (empirical model)
A multivariate analysis for log(WIN-TIFP) and the MRI vascular parameters TBF, TBF -rim , TBF -peri , K trans , K trans 2rim , V D , V D-rim , V D-peri , and v were applied. These parameters were estimated in the 3 different ROIs as described in Figure 2 (whole tumor, tumor rim, tumor periphery), and are believed to have different physiological characteristics and may affect TIFP differently. The AIC was used as a selection method to determine which set of these tumor parameters was the best predictor of TIFP. There were 4 parameters that best described TIFP and had the lowest AIC value (AIC 5 37. Based on the result of the multivariate analysis, an empirical model for estimating log TIFP was established (MRI-TIFP E ), consisting of linear regression of these 4 parameters. A regression analysis of these predictors on the entire data set was performed, yielding regression coefficients as follows: V D in the tumor (27.6), v at the tumor surface (157), TBF -peri in the adjacent normal tissue surrounding the tumor (20.0119), TBF in the tumor (0.0113), and intercept (2.55). The R 2 for the linear regression analysis was 0.8 (p < 10
26
). Results of a cross-validation leave-one-out analysis (re-estimation of log(MRI-TIFP E ) for each point with that point omitted from the regression model) are shown in Figure 5A . A leave-one-out cross-validation analysis yielded an R 2 of 0.67 (p < 10
). Thus, it can be said with some confidence that noninvasive DCE-MRI and perfusion measures combined contain sufficient information to predict TIFP.
The subgroups were examined with a similar linear regression analysis that used the same 4 parametric predictors as in the combined analysis (V D , v, TBF -peri , and TBF tumor ), with a separate log(MRI-TIFP E ) constructed for each subgroup. Even in these relatively small groups (n 5 11, 9, and 9 for controls, bevacizumab, and Cilengitide1RT, respectively, in which the sample size for Cilengitide1RT was reduced by one as a result of missing values for blood flow), some significant correlations were found between log(WIN-TIFP) and log(MRI-TIFP E ), as shown in Figure 5B ,C. In the control group, despite an R 2 of 0.66, the relationship was not significant (p 5 .12). The cross-validation study confirmed this result (R 2 5 0.17, p 5 .21). However, in the bevacizumab group, log(MRI-TIFP E ) remarkably predicted log (WIN-TIFP) with an R 2 of 0.93 (p 5 .014). The crossvalidation study maintained this result (R 2 5 0.66, p < .01).
In the Cilengitide1RT group, log(MRI-TIFP E ) predicted log (WIN-TIFP) with an R 2 of 0.87 (p 5 .045), somewhat weakened by the cross-validation study (R 2 5 0.39, p 5 .072).
F IGUR E 4 Wick-in-needle (WIN) TIFP versus MRI-TIFP D based
on the fluid-mechanical model for U251 tumor groups: control, bevacizumab, and Cilengitide1RT. All groups showed significant positive correlations
| D IS C US S I ON
Two approaches to the problem of noninvasively estimating TIFP have been presented: The first is a model-based approach that uses well-established fluid-mechanics theory, and the second is an empirical approach that tests measures that might contribute to measured TIFP. The mean plateau TIFP pressure was quite variable (1.6 to 14.9 mmHg) across animals. The central TIFP of an embedded tumor depends on sources and sinks. 30 Sources are affected by perfusion pressure, local tumor blood flow, vascular resistance, TIFP itself, and vascular permeability. Sinks are affected by tumor size, tumor extracellular space, peritumoral compression, and probably such other factors as intracerebral fluid pressure and venous reabsorption. The measured TIFP is a complex function of all these terms. Both models of TIFP point to the distribution volume, V D , as a principal factor in determining TIFP. In the deterministic Darcy model, V D (i.e., porosity, u) is identified as an essential element in calculating the tissue fluid conductivity, and thus is essential to describing the flow of interstitial fluid to its sink. In the empirical model, we see that 2 source terms, flow in the tumor periphery and flow in the tumor itself, were added to V D to predict the central TIFP. It appears that tumor growth rate, reflected in V D , is a major factor determining TIFP, and it appears to be that tumor metabolic demand, reflected in perfusion, is also a determinant of TIFP.
In the fluid-mechanical approach, a noninvasive DCE-MRI method for estimating hydraulic conductivity and TIFP in a rat model of embedded cerebral tumor is presented. The method is based on the theory of fluid convection in porous media and uses previously presented methods for estimating tumor porosity 17 and exudate fluid velocity at the tumor periphery. 16 Hydraulic conductivity was estimated by using the KC equation, 14 and TIFP was estimated via Darcy's law. Estimates of TIFP were performed in a U251 rat model of cerebral glioblastoma, with and without treatment intervention, to create variations in TIFP across the sample of animals. Invasive WIN TIFP measurements were performed immediately after the DCE-MRI study in all rats to verify MRI-TIFP estimations. Previous measurements of the hydraulic conductivities of tumors are limited because of the experimental difficulties in evaluating this parameter, with in vitro estimates generated by applying Darcy's law, 40, 41 and more recently ex vivo by confined compression tests. 33 A few studies have attempted an in vivo estimate of hydraulic conductivity. 38, 41, 42 However, most of these in vivo estimates were not straightforward, because of the difficulties in defining the geometric tissue dimensions. In general, hydraulic conductivity has been expressed as a function of porosity. In particular, the KC equation, a widely accepted model for estimating hydraulic conductivity, has depended primarily on porosity, with most parameters such as specific surface area, tortuosity, and shape factor related to porosity. 32 In this study, the estimated MRI-K values for U251 tumors were in the range of estimates in other tumors. 33, 34, 38, 39 The mean of MRI-K in the control group was (2.3 6 3.1) 3 10 25 mm 2 /mmHg-s. However, Table 1 lists a wide range of MRI-K values among studies, reflecting the dependency of MRI-K on the porosity of each individual tumor and showing the important contribution of the extracellular matrix to the hydraulic conductivity.
Because we had no direct in vivo estimates for the total specific surface area, there was some limitation in estimating MRI-K. Commonly, in studies of filtration in porous media, the surface area is calculated by using the grain dimensions; however, in the case of tissue, surface area is dependent on the wetted surface of the cells, plus that of the extracellular matrix. A consideration of only the cell dimensions will result in an overestimation of hydraulic conductivity. Our data from the control sample showed that S was variable across tumors with a range of 1091 to 2169 mm 21 . Although our best available strategy for approaching the problem of estimating TIFP via the Darcy approach, using the group mean to construct an approximate estimation of S across the U251 tumors probably did introduce a range of errors into the estimates thereby generated.
Some estimate of relative wetted surface area in tumors should be included in future experimental approaches to TIFP estimates. The MRI contrast mechanisms, T 1 , T 2 and T Ã 2 , depend on the interaction between the solid tissue compartment and the liquid compartment, and that interaction is strongly dependent on the amount of surface that the mobile protons of the liquid compartment experience. For instance, the forward magnetization transfer ratio is strongly dependent on the amount of free water, compared with the amount of protein, in a given tissue. 43 This generates the possibility that, given a calibration for surface area by some other means, the magnetization transfer ratio might serve as a surrogate measure of wetted surface area in tissue, albeit that estimate would have to be adjusted for intracellular/extracellular moieties. Tumor IFP has been evaluated noninvasively using DCE-MRI in a limited number of studies 8, 9 ; these attempts assumed tumor models with fixed porosity and hydraulic conductivity. Neglecting the individual tumor's differences in hydraulic conductivity in determining TIFP may lead to substantial systematic errors in estimation of TIFP. For instance, Figure 6 displays a poor correlation between the MRI-TIFP and WIN-TIFP when a fixed value of hydraulic conductivity was applied instead of the porosity-adjusted MRI-K. In contrast, our estimate of MRI-TIFP D showed good correlations with the WIN-TIFP (Figure 4) , showing that hydraulic conductivity estimated from the measured porosity of the tissue is an essential factor in estimating TIFP. These results were supported by the multivariate analysis of WIN-TIFP, showing that V D in the tumor (i.e., tumor porosity), the main factor in estimating hydraulic conductivity, was found to be the tumor parameter to most descriptive of TIFP (p 5 .0002).
In this model of cerebral glioma, significant results were found in all groups. The estimated MRI-TIFP D in the control group was a strong predictor of WIN-TIFP with p < .0001. After interventions with 2 different treatments, bevacizumab and combined therapy of Cilengitide and RT, the same strong correlations between MRI-TIFP D and WIN-TIFP were found with p 5 .009 and p 5 .005, respectively. However, our estimates, although highly correlated, systematically underestimated TIFP in the bevacizumab and Cilengitide1RT groups. It may be that, because the specific surface area was estimated from the control group and then applied in the treated groups, the specific surface area was affected by the applied treatments, and in turn affected the estimates of the individual MRI-K. Another explanation is provided by the multivariate analysis, which showed that, besides porosity and fluid exudate velocity at the tumor surface, WIN-TIFP was significantly predicted by the TBF -peri (i.e., flow in the normal tissue surrounding the tumor and TBF in the tumor itself), implying that adding the latter 2 parameters in the MRI-TIFP D estimating model might yield better estimates.
We have noted that it is unlikely that overfitting of data occurred when estimating tumor porosity and exudate fluid velocity. between the vascular concentration and the extravascular concentration. These 2 approaches use different segments of tissue concentration data: The Patlak model draws information from the early, rapidly changing segment, whereas the Logan model draws information from the later, equilibrated segment. Although the two approaches do use the same data, it appears unlikely that overfitting occurs. A check against overfitting is supplied by the empirical model, which systematically eliminates variables that do not contribute significantly and uniquely to the description of the data. In the empirical approach, when terms that reflected fluid sources were added to those of the Darcy model, significant results were found in the entire population, and in the bevacizumab and Cilengitide1RT subgroups ( Figure 5A,C,D) . The estimated log(MRI-TIFP E ) was a predictor of log(WIN-TIFP) in both groups, despite the small sample sizes of those groups. These relations persisted under a more rigorous cross-validation study.
There may be a concern that the administration of bevacizumab suppresses evidence of contrast agent leakage to such an extent that the experimental methods outlined herein are invalidated. However, it appears that the U251 glioma in the rat cerebral vascular behaves differently from human gliomas after bevacizumab; although K trans does decrease, we see no evidence of a wholesale suppression of vascular permeability (see Supporting Information Figure S2 ). In the empirical approach, WIN-TIFP correlated highly with estimates of TIFP in the bevacizumab group. It may be that effects not included in the main empirical model were diminished by the treatment, and that this improved its predictive ability. One possibility is that a decrease in the vascular reabsorption of CA in the vasculature of the mostly normal rim of the tumor increased the fidelity of the model, as vascular re-absorption and (probably) more rapid clearance was not reflected in the measures being made. As noted, R 2 for all models decreased (as expected) in all of the cross-validation studies, but the general impression remains that there is sufficient information in noninvasive MRI studies to reliably predict tumor interstitial fluid pressure in this tumor model, and possibly in other tumors with similar characteristics. A note of caution is necessary. In vascular beds other than cerebral, where K trans is more strongly related to perfusion, some weightings may change. Because K trans , whether diffusion-limited or not, is a measure of fluid delivery to the tumor, it would be an important contributor to the TIFP if perfusion weighted more significantly in its value. In that case, in an empirical approach, it might be that the source term in the source minus sink balance would have to include K trans , with perfusion in the tumor and rim not as heavily weighted as in cerebral tumors. For future work, a more complete model that considers tissue compression, perfusion, and permeability is likely needed to fully describe fluid mechanics in solid tumors.
In summary, MRI-TIFP estimates constructed by using fluid-mechanical and empirical models were generally well correlated with WIN-TIFP measures. It is likely that a more complete poroelastic model that considers both sources (perfusion, permeability) and sinks (porosity, local pressures) can yield a noninvasive estimate of TIFP in both controls and treated groups.
